相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biological activities of Ficus carica latex for potential therapeutics in Human Papillomavirus (HPV) related cervical cancers
Arshia Ghanbari et al.
SCIENTIFIC REPORTS (2019)
Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer
Rashmi Deshpande et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)
CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6
Takahiro Yoshiba et al.
ONCOLOGY LETTERS (2019)
Epidemiology and burden of HPV-related disease
Beatriz Serrano et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2018)
Synthetic siRNA targeting human papillomavirus 16 E6: a perspective on in vitro nanotherapeutic approaches
Melissa Togtema et al.
NANOMEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design
Sumitra Shankar et al.
CANCER CELL INTERNATIONAL (2018)
Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model
Benjamin Y. Jin et al.
JCI INSIGHT (2018)
Therapeutic vaccines for high-risk HPV-associated diseases
Aleyo Chabeda et al.
PAPILLOMAVIRUS RESEARCH (2018)
Integrated genomic and molecular characterization of cervical cancer
Robert D. Burk et al.
NATURE (2017)
Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation
Yiyu Zhang et al.
ONCOTARGET (2017)
TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells
Sumitra Shankar et al.
SCIENTIFIC REPORTS (2017)
Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery
Anna W. LaVigne et al.
GYNECOLOGIC ONCOLOGY REPORTS (2017)
Global Cancer in Women: Burden and Trend
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering
Addison V. Wright et al.
CELL (2016)
Current state in the development of candidate therapeutic HPV vaccines
Andrew Yang et al.
EXPERT REVIEW OF VACCINES (2016)
Cudrania tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells
Sae-Bom Kwon et al.
PLOS ONE (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
Myc and cell cycle control
Gabriel Bretones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer
Radha Munagala et al.
CANCER LETTERS (2015)
Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
Lindsey M. Draper et al.
CLINICAL CANCER RESEARCH (2015)
Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus-Targeted Tumor-Infiltrating T Cells
Sanja Stevanovic et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
Cornelia L. Trimble et al.
LANCET (2015)
An updated evolutionary classification of CRISPR-Cas systems
Kira S. Makarova et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Human papillomavirus molecular biology and disease association
John Doorbar et al.
REVIEWS IN MEDICAL VIROLOGY (2015)
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
Zheng Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer
N. Wang et al.
BRITISH JOURNAL OF CANCER (2014)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Zinc Finger Nucleases Targeting the Human Papillomavirus E7 Oncogene Induce E7 Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells
Wencheng Ding et al.
CLINICAL CANCER RESEARCH (2014)
Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease
Edward M. Kennedy et al.
JOURNAL OF VIROLOGY (2014)
Expression of Suppressor of Cytokine Signaling 1 (SOCS1) Impairs Viral Clearance and Exacerbates Lung Injury during Influenza Infection
Keer Sun et al.
PLOS PATHOGENS (2014)
p53 family and cellular stress responses cancer
Johanna Pflaumf et al.
FRONTIERS IN ONCOLOGY (2014)
Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells
Man Sub Kim et al.
CELL BIOLOGY AND TOXICOLOGY (2013)
Immune alterations and immunotherapy prospects in head and neck cancer
Vincent Varilla et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53
A. Reschner et al.
GENE THERAPY (2013)
Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells
Xiying Qu et al.
NUCLEIC ACIDS RESEARCH (2013)
Gene- and Protein-Delivered Zinc Finger-Staphylococcal Nuclease Hybrid for Inhibition of DNA Replication of Human Papillomavirus
Takashi Mino et al.
PLOS ONE (2013)
Structure Based Identification and Characterization of Flavonoids That Disrupt Human Papillomavirus-16 E6 Function
Jonathan J. Cherry et al.
PLOS ONE (2013)
Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines
Margaret E. McLaughlin-Drubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Thomas Gaj et al.
TRENDS IN BIOTECHNOLOGY (2013)
The HPV16 E6 Oncoprotein Causes Prolonged Receptor Protein Tyrosine Kinase Signaling and Enhances Internalization of Phosphorylated Receptor Species
Jennifer M. Spangle et al.
PLOS PATHOGENS (2013)
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Subhashini Sadasivam et al.
NATURE REVIEWS CANCER (2013)
Comprehensive Analysis of Host Cellular Interactions with Human Papillomavirus E6 Proteins Identifies New E6 Binding Partners and Reflects Viral Diversity
Elizabeth A. White et al.
JOURNAL OF VIROLOGY (2012)
Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase
Gregory Neveu et al.
METHODS (2012)
Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
Zarina J. D'Costa et al.
PLOS ONE (2012)
Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses
Elizabeth A. White et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
Mark L. Bagarazzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Solution Structure Analysis of the HPV16 E6 Oncoprotein Reveals a Self-Association Mechanism Required for E6-Mediated Degradation of p53
Katia Zanier et al.
STRUCTURE (2012)
Modulation of Apoptotic Pathways by Human Papillomaviruses (HPV): Mechanisms and Implications for Therapy
Chung-Hsiang Yuan et al.
VIRUSES-BASEL (2012)
Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
Shinta Tan et al.
MOLECULAR PHARMACOLOGY (2012)
Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells
Radha Munagala et al.
CARCINOGENESIS (2011)
Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells
Nurshamimi Nor Rashid et al.
JOURNAL OF GENERAL VIROLOGY (2011)
Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells
Sutapa Mahata et al.
MOLECULAR CANCER (2011)
Papillomavirus E5: the smallest oncoprotein with many functions
Aldo Venuti et al.
MOLECULAR CANCER (2011)
Nordihydroguaiaretic acid inhibits growth of cervical cancer SiHa cells by up-regulating p21
Peng Gao et al.
ONCOLOGY LETTERS (2011)
The Human Papillomavirus Type 16 E6 Oncoprotein Activates mTORC1 Signaling and Increases Protein Synthesis
Jennifer M. Spangle et al.
JOURNAL OF VIROLOGY (2010)
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
Hans-Ulrich Bernard et al.
VIROLOGY (2010)
Expression of a viral oncoprotein in normal human epithelial cells triggers an autophagy-related process
Xiaobo Zhou et al.
AUTOPHAGY (2009)
Persistence of High-Grade Cervical Dysplasia and Cervical Cancer Requires the Continuous Expression of the Human Papillomavirus Type 16 E7 Oncogene
Sean F. Jabbar et al.
CANCER RESEARCH (2009)
Efficient double-stranded DNA cleavage by artificial zinc-finger nucleases composed of one zinc-finger protein and a single-chain FokI dimer
Takashi Mino et al.
JOURNAL OF BIOTECHNOLOGY (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
HPV E6 protein interacts physically and functionally with the cellular telomerase complex
Xuefeng Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivation
Xiaobo Zhou et al.
VIROLOGY (2009)
HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition
Karin Hellner et al.
VIROLOGY (2009)
New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
K. Yamato et al.
CANCER GENE THERAPY (2008)
RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53
Ni Sima et al.
APOPTOSIS (2008)
Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes
Xuefeng Liu et al.
JOURNAL OF VIROLOGY (2007)
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins
T. O. Garnett et al.
ARCHIVES OF VIROLOGY (2006)
Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7
O. Ohlenschlaeger et al.
ONCOGENE (2006)
MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors
M. Peter et al.
ONCOGENE (2006)
Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFKB and AP-1 translocation and modulation of apoptosis
CS Divya et al.
MOLECULAR CARCINOGENESIS (2006)
Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt
SH Kim et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Structural and functional analysis of E6 oncoprotein:: Insights in the molecular pathways of human papillomavirus-mediated pathogenesis
Y Nominé et al.
MOLECULAR CELL (2006)
Effects of human papillomavirus type 16 oncoproteins on survivin gene expression
AA Borbély et al.
JOURNAL OF GENERAL VIROLOGY (2006)
The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation
BY Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibitory effect of jaceosidin isolated from Artemisia argyi on the function of E6 and E7 oncoproteins of HPV 16
HG Lee et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase
ML Kelley et al.
JOURNAL OF VIROLOGY (2005)
Molecular pathways executing the trophic sentinel response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation
A Eichten et al.
VIROLOGY (2004)
Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex
L Gewin et al.
GENES & DEVELOPMENT (2004)
Ribozyme targeting HPV16 E6E7 transcripts in cervical cancer cells suppresses cell growth and sensitizes cells to chemotherapy and radiotherapy
YF Zheng et al.
CANCER BIOLOGY & THERAPY (2004)
Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras
O Chakrabarti et al.
JOURNAL OF VIROLOGY (2004)
Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression
HR McMurray et al.
JOURNAL OF VIROLOGY (2003)
E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes
Y Kim et al.
CANCER GENE THERAPY (2003)
Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter
T Veldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A mutant of human papillomavirus type 16 E6 deficient in binding α-helix partners displays reduced oncogenic potential in vivo
M Nguyen et al.
JOURNAL OF VIROLOGY (2002)
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation
M Thomas et al.
ONCOGENE (2002)
The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis
M Filippova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Oncogenes and tumor angiogenesis:: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner
O López-Ocejo et al.
ONCOGENE (2000)
分享论文
